Skip to main content

CALLAN JMB INC.

For the period ended Mar 31, 2026. Filed May 15, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 15, 2026

CJMB$0.28-0.7%Stored close · as of Nov 6, 2026

What changed in Risk Factors?

Read the current filing

Previous report: 10-Q

Period ended 2025-09-30; filed 2025-11-14.

0001493152-25-023475

Item 1A. RISK FACTORSUNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Current report: 10-Q

Period ended 2026-03-31; filed 2026-05-15.

0001493152-26-023708

Item 1A. RISK FACTORSUNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 5 previous paragraphs and 7 current paragraphs.

3 unchanged; 1 reworded; 3 added; 1 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (3)

Current report

Our common stock may be delisted from The Nasdaq Capital Market if we do not regain compliance with Nasdaq’s continued listing requirements.

Current report

On April 7, 2026, we received a deficiency letter (the “Notice”) from Nasdaq notifying us that we were not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2,500,000 in stockholders’ equity for continued listing on The Nasdaq Capital Market. We have until May 22, 2026 to submit a plan to regain compliance, and if Nasdaq accepts the plan, Nasdaq may grant us up to 180 calendar days from the date of the Notice, or until October 4, 2026, to evidence compliance. The Notice does not have an immediate effect on the listing or trading of our common stock; however, if Nasdaq does not accept our plan or if we fail to regain compliance within the applicable period, our common stock could be delisted, which could adversely affect the liquidity and market price of our common stock and our ability to raise capital.

Current report

During the quarter ended March 31, 2026, no unregistered sales of equity securities occurred.
Removed paragraphs (1)

Previous report

As of September 30, 2025, the Company issued approximately 123,208 shares of Common Stock under the ELOC Facility for net proceeds of approximately $497,750.
Reworded paragraphs (1)

Previous wording

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

Current wording

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item. Notwithstanding the foregoing, the following risk factor supplements the risk factors, if any, previously disclosed in our filings with the SEC.